Information  X 
Enter a valid email address

Company Name matching 'Novavax, Inc.'

Date
Time Source
Company
Announcement
04 Dec 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Announces Leadership Promotions
12 Nov 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Expands Leadership with Several Key Management Promotions
07 Nov 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Reports Third Quarter 2018 Financial Results
01 Nov 2018 8:15 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018
  8:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Appoints Rachel King to Board of Directors
02 Oct 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Highlight RSV Program Data at Two Upcoming Meetings
26 Sep 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Present at Two Upcoming Investor Conferences
25 Sep 2018 12:00 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults
28 Aug 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Participate at Two Upcoming Investor Conferences
08 Aug 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Reports Second Quarter 2018 Financial Results
01 Aug 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 8, 2018
13 Jun 2018 10:10 pm GNW   Factsheet Novavax, Inc. (0UP6) New England Journal of Medicine Publishes Novavax' NanoFlu Clinical Trial Data
09 May 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Reports First Quarter 2018 Financial Results
07 May 2018 12:00 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Reaches Significant Enrollment Milestone in the Prepare(TM) Phase 3 Trial of its RSV F Vaccine
02 May 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 9, 2018
16 Apr 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Announces Closing of Public Offering
12 Apr 2018 2:00 am GNW   Factsheet Novavax, Inc. (0UP6) Novavax Prices Public Offering of Common Stock
02 Apr 2018 2:00 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Present Clinical Data on RSV F and NanoFlu(TM) Vaccines at World Vaccine Congress
14 Mar 2018 8:19 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results
  8:08 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer
07 Mar 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call and Webcast to Provide Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results
28 Feb 2018 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax, Inc. : Novavax NanoFlu(TM) Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
18 Dec 2017 9:56 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu(TM) Vaccine
08 Nov 2017 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Present at the Stifel 2017 Healthcare Conference
07 Nov 2017 9:06 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Reports Third Quarter 2017 Financial Results
31 Oct 2017 8:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss Third Quarter 2017 Financial Results on November 7, 2017
13 Oct 2017 12:30 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Announces Leadership Change
19 Sep 2017 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference
  2:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Initiates Phase 1/2 Trial of NanoFlu(TM) Vaccine in Older Adults
05 Sep 2017 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Participate in the Citi 12th Annual Biotech Conference
23 Aug 2017 12:00 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax' Preclinical Influenza Nanoparticle Study Published in Vaccine
08 Aug 2017 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Reports Second Quarter 2017 Financial Results
01 Aug 2017 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on August 8, 2017
24 Jul 2017 9:05 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs
07 May 2015 9:50 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Reports First Quarter 2015 Financial Results
30 Apr 2015 9:06 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 7, 2015
08 Apr 2015 9:02 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Present at the 14th Annual Needham Healthcare Conference
31 Mar 2015 9:02 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Announces Closing of Public Offering
28 Mar 2015 1:37 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Presents New Data From Non-Human Primate Ebola Challenge at the 7th International Symposium on Filoviruses
26 Mar 2015 12:01 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Prices Public Offering of Common Stock
24 Mar 2015 8:09 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Announces Proposed Public Offering of Common Stock
10 Mar 2015 8:16 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Appoints Brian Rosen as Vice President, Government Affairs
26 Feb 2015 9:37 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Reports Fourth Quarter and Year-End 2014 Financial Results
19 Feb 2015 9:06 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015
12 Feb 2015 1:31 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Announces Initiation of Ebola Vaccine Phase 1 Clinical Trial Supported by Non-Human Primate Challenge Data and Documented Rapid Manufacturing Capabilities
08 Jan 2015 9:06 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Announces Management Promotion
07 Jan 2015 3:17 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference
26 Nov 2014 1:33 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Present at the 26th Annual Piper Jaf...
20 Nov 2014 1:34 pm GNW   Factsheet Novavax, Inc. (0UP6) U.S. FDA Grants Fast Track Designation to Novav...
17 Nov 2014 9:07 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Initiates Phase 2 Clinical Trial of Qua...
13 Nov 2014 2:34 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Present at the Jefferies Global Heal...
10 Nov 2014 1:32 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Initiates Phase 1 Clinical Trial of RSV...
06 Nov 2014 10:36 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax and Collaborators Make Multiple Present...
05 Nov 2014 9:34 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Reports Third Quarter 2014 Financial Re...
30 Oct 2014 12:32 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss Thir...
29 Oct 2014 9:34 pm GNW   Factsheet Novavax, Inc. (0UP6) U.S. FDA Grants Fast Track Designation to Novav...
27 Oct 2014 11:32 am GNW   Factsheet Novavax, Inc. (0UP6) Novavax Announces Ebola Vaccine Development Pro...
26 Oct 2014 2:10 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Presents RSV F Protein Nanoparticle Vac...
23 Oct 2014 9:24 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax to Present RSV Vaccine Clinical Data at...
15 Oct 2014 1:33 pm GNW   Factsheet Novavax, Inc. (0UP6) Novavax Study Published in Vaccine: RSV F-Prote...


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t